DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Manidipine

Manidipine

  • Summary of Product Characteristics

    Summary of Product Characteristics

  • The Repurposing Drugs in Oncology Database

    The Repurposing Drugs in Oncology Database

  • Guidelines of Hypertension – 2020 Barroso Et Al

    Guidelines of Hypertension – 2020 Barroso Et Al

  • Ovid MEDLINE(R)

    Ovid MEDLINE(R)

  • 174-Atypical Antipsychotics and Sleepwalkingsleep-Related Eating

    174-Atypical Antipsychotics and Sleepwalkingsleep-Related Eating

  • Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews

    Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews

  • Interactions Between Antihypertensive Drugs and Food B

    Interactions Between Antihypertensive Drugs and Food B

  • Wo 2011/060944 A2

    Wo 2011/060944 A2

  • The Claimed Intermediate Online Database | Drug Names to Search: Control F (PC) Command F (Mac) Open & Search in Ibooks App (Ipad)

    The Claimed Intermediate Online Database | Drug Names to Search: Control F (PC) Command F (Mac) Open & Search in Ibooks App (Ipad)

  • Combined Poziotinib with Manidipine Treatment Suppresses Ovarian Cancer Stem-Cell Proliferation and Stemness

    Combined Poziotinib with Manidipine Treatment Suppresses Ovarian Cancer Stem-Cell Proliferation and Stemness

  • Uncontrolled Hypertension Based on Morning and Evening Home Blood Pressure Measurements from the J-HOME Study

    Uncontrolled Hypertension Based on Morning and Evening Home Blood Pressure Measurements from the J-HOME Study

  • Drug Repurposing for Mitochondrial Diseases Using a Pharmacological Model of Complex I Deficiency in the Yeast Yarrowia Lipolytica

    Drug Repurposing for Mitochondrial Diseases Using a Pharmacological Model of Complex I Deficiency in the Yeast Yarrowia Lipolytica

  • (12) Patent Application Publication (10) Pub. No.: US 2008/0312247 A1 Gant Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2008/0312247 A1 Gant Et Al

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • Supplement Ii to the Japanese Pharmacopoeia Seventeenth Edition

    Supplement Ii to the Japanese Pharmacopoeia Seventeenth Edition

  • Supplement I to JP XV

    Supplement I to JP XV

  • Supplementary Figure Legends Figure S1. Azelastine Inhibits the Proliferation of CRC Cells with No Toxic Effects in Mice. (A) Co

    Supplementary Figure Legends Figure S1. Azelastine Inhibits the Proliferation of CRC Cells with No Toxic Effects in Mice. (A) Co

  • PACKAGE LEAFLET: INFORMATION for the USER /.../ 10 Mg Tablets

    PACKAGE LEAFLET: INFORMATION for the USER /.../ 10 Mg Tablets

Top View
  • Pharmacological Drugs Inducing Ototoxicity, Vestibular Symptoms and Tinnitus: a Reasoned and Updated Guide
  • Calcium Channel Ca2+ Channels;Ca Channels
  • Annexure‐ I : Specifications of FDA Approved Drug Library
  • Www .Alfa.Com
  • Supplementary Table. Major Interactions Between Drugs Patient Code First Drug Second Drug
  • Drug Class Review on Calcium Channel Blockers
  • Role of Membrane Transporters in Drug Delivery, Drug Disposition and Drug-Drug Interactions
  • Ep 1203580 A1
  • 1 Drugs for Ischemic Heart Disease WILLIAM E
  • Manidipine Hydrochloride Maprotiline
  • Statistical Analysis Plan: 20140254 Date: 07 January 2017 Page 24
  • Colloidal Aggregators in Biochemical SARS-Cov-2 Repurposing Screens
  • UCSF UC San Francisco Previously Published Works
  • Ribociclib: Drug Information
  • General Information
  • What Kinds of Patients Requires Prophylactic Therapy?
  • Summary of Products Characteristics 1 Name Of
  • Wo 2007/044693 A2


© 2024 Docslib.org    Feedback